Accelerate to discover

Homepage>Discover>A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy

Mar 30, 2020

As the public health threat from COVID-19 and future emergent viruses continue to persist, the rapid, sensitive, and...

Genotype-targeted local therapy of glioma

Mar 26, 2020

Lower-grade gliomas are often characterized by mutations in metabolism-related genes isocitrate dehydrogenase 1 (IDH1)...

Cytek spectral cytometers: 21 color panels with just 2 lasers

Mar 23, 2020

Until recently, developing multicolor fluorescence-based flow cytometry assays on a two laser system has been limited...

Cancer cells resist mechanical destruction in the circulation via RhoA-myosin II axis

Mar 20, 2020

Tumors may generate millions of Circulating tumor cells per day, but seminal work in cancer biology has established the...

Mar 31, 2020

IncuCyte live cell analysis system for 3D Organoids discovery

Mar 18, 2020

Live-Cell Analysis has revolutionized numerous studies, with a wide selection of applications namely 3D Tumour Spheroid...

Webinar recording: Ex vivo microangioCT, advances in microvascular imaging

Mar 16, 2020

A new technique called microangioCT imaging is being used with a novel polymerizing contrast agent that enables 3D...

Single Cell Sequencing sample preparation without centrifugation

Mar 10, 2020

Single-cell genomics is rapidly growing. Nature Methods named multimodal omics the method of the year for 2019. And as...

Mar 31, 2020

Comparing image quality in Phase Contrast X-Ray Tomography

Feb 28, 2020

How to evaluate and compare image quality from different submicrometer CT scans? A simple yet clever test phantom is...

Show all topics (10)

A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy

Sep 18, 2018

Antigen-specific cytotoxic T lymphocytes (CTLs), which eliminate target cells bearing antigenic peptides presented by surface major histocompatibility complex (MHC) class I molecules, play a key role in cancer immunotherapy. However, the majority of tumors are not immunologically rejected since they express self-antigens which are not recognized by CTLs as foreign. To foreignize these tumors for CTL-mediated immunological rejection, it is essential to develop carriers that can effectively deliver foreign antigens to cancer cells.

Do you want to learn more? Read this interesting article!

Scientific paper

Application

Get more info